Making the Most of Your 340B Program with a Comprehensive Pharmacy Strategy

SPONSORED CONTENT

The world of 340B has been in a state of dynamic change for several years. The covered entities navigating it with the most success have comprehensive pharmacy strategies. This helps them maximize both the value of their participation and the opportunities provided by pharmacy services and the 340B program.

In this article, we’ll review what goes into creating a comprehensive pharmacy strategy, including important questions to consider, pharmacy enterprise development, and performance optimization.

3 Key Questions to Consider

Launching your strategy beyond contract pharmacy and split billing requires answering critical questions for your entity:

  • What is the right mix of pharmacy services for your health center, hospital, or health system?
  • How can you improve the performance of the services you have?
  • What else can you offer that supports your patients and creates financial value?

Through our consulting services, Hudson Headwaters 340B works with covered entities to

Read More »

Expert Tip from Apexus

img
img

TIP: Want to resolve negative 340B accumulations to improve your organization’s 340B compliance? Simplify your process for refunding manufacturers with the Apexus Covered

Read More »

Visante Webinar: 340B Current Issues and Policy Update

SPONSORED CONTENT

Join us for in an informative and timely 340B webinar scheduled for March 13th at 11:30 AM CT! Ted Slafsky, CEO of 340B Report, and Kristin Fox-Smith from Visante will share insights on 340B policy and litigation updates, along with valuable strategies to enhance and streamline your 340B program. Registration is complimentary, but spots are limited, so secure your spot today!

Visante logo and tagline
Read More »

Part 2 of 2: Understanding the Top Five Challenges Facing Health Center Pharmacies Today

Holly Russo headshot

SPONSORED CONTENT

Part 2 of 2: Navigating staffing shortages, unpredictable demand, and complex industry requirements

While in-house pharmacies offer a wide array of benefits both for the community health center (CHC) and their patient populations, overseeing the myriad of administrative, operational, financial, and regulatory intricacies can prove difficult to manage. In Part 1 of this series, we covered two of the biggest challenges that CHCs face while operating in-house pharmacies: managing costs and ensuring favorable contracting.

In this follow-up, we explore the pressures facing CHCs due to pervasive staffing and retention challenges, fluctuating levels of patient demand, and nuanced regulatory complexities—and how CHCs can act to boost patient demand, improve clinical outcomes, and reinforce their financial health in 2024 and beyond. This is part two of a two-part series.

Challenge 3: Staffing shortages

Attracting and retaining pharmacy talent has

Read More »

Part 1 of 2: Understanding the Top Five Challenges Facing Health Center Pharmacies Today

Holly Russo headshot

SPONSORED CONTENT

Part 1 of 2: Managing costs and ensuring favorable contracting

As industry veterans know too well, having an in-house pharmacy can be greatly beneficial for both community health centers (CHCs) and their patients. Not only do they offer patient convenience and a greater level of transparency into medication adherence or prescription abandonment, but they also allow for improved engagement and educational opportunities, the potential for revenue growth, and enhancements to clinical programs that can translate directly into better health outcomes.

However, in-house pharmacies face a growing set of challenges, from managing purchasing and inventory to rising drug costs, drug shortages, unpredictable patient demand, payer contracting, staffing shortages, and regulatory complexities. And, as at least half of the average CHC patient populations is covered by Medicaid,[1] the program’s unwinding of its continuous enrollment provision will mean an additional

Read More »

Reflecting on Winter Coalition 2024

SPONSORED CONTENT

Last week, the 340B community gathered in the sun-soaked city of San Diego to gain insights, exchange best practices, and navigate the evolving complexities surrounding the program. Whether you missed the 340B Coalition winter event altogether or are seeking a recap to share with your team, this article aims to highlight the pivotal developments and discussions that took place, poised to shape the landscape of 340B in the months ahead.

Genesis Healthcare v. Becerra: Unpacking the Implications

Likely the most anticipated and highly attended session of the conference, the 340B Coalition kicked off the Winter Coalition with a panel discussion focused on implications of the recent court ruling, Genesis Healthcare v. Becerra. In November 2023, a South Carolina District Court ruled against HRSA, noting that nothing in the 340B statute or regulations supported HRSA’s interpretation that a 340B prescription had to originate from care at the covered entity. This decision has been

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report